Expertise in
5
conditions

Julien Maizel

Amiens, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
5
conditions
Amiens, FR 
OverviewLocationsClinical Research

Overview

Julien Maizel practices in Amiens, France. Mr. Maizel is highly rated in 5 conditions, according to our data. His top areas of expertise are Sepsis, Acute Respiratory Distress Syndrome (ARDS), Lactic Acidosis, and Cerebral Hypoxia.

His clinical research consists of co-authoring 111 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Amiens, France
Other Locations
Paris, France
Lille, 59000, France
Dieppe, France
Toulon, France
France 1, Rue Du Professeur Christian Cabrol 80054 Amiens Cedex, Rouez, 80054, France
Angers, France
Poitiers, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion: a Randomized Controlled Multi-center Trial
Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion: a Randomized Controlled Multi-center Trial
Enrollment Status: Recruiting
Publish Date: January 17, 2025
Intervention Type: Drug
Study Drug: Dobutamine
Study Phase: Phase 3
Does High-dose Vitamin B3 Supplementation Prevent Major Adverse Kidney Events During Septic Shock? A Multicenter Randomized Controlled Study
Does High-dose Vitamin B3 Supplementation Prevent Major Adverse Kidney Events During Septic Shock? A Multicenter Randomized Controlled Study
Enrollment Status: Active_not_recruiting
Publish Date: August 24, 2025
Intervention Type: Drug
Study Drug: Nicotinamide
Study Phase: Phase 3
A Randomized, Double-blind, Placebo-controlled, Study Evaluating the Efficacy and Safety of Otilimab IV in Patients With Severe Pulmonary COVID-19 Related Disease
A Randomized, Double-blind, Placebo-controlled, Study Evaluating the Efficacy and Safety of Otilimab IV in Patients With Severe Pulmonary COVID-19 Related Disease
Enrollment Status: Completed
Publish Date: September 23, 2024
Intervention Type: Biological, Drug
Study Drugs: Otilimab, Standard of Care
Study Phase: Phase 2
Evaluation of Prone Position in Conscious Patients on Nasal High-flow Oxygen Therapy for COVID-19 Disease Induced Acute Respiratory Distress Syndrome
Evaluation of Prone Position in Conscious Patients on Nasal High-flow Oxygen Therapy for COVID-19 Disease Induced Acute Respiratory Distress Syndrome
Enrollment Status: Completed
Publish Date: April 19, 2021
Intervention Type: Other
Study Phase: Not Applicable
Prognostic Assessment of Diastolic and Systolic Left Ventricular Function in Septic Shock
Prognostic Assessment of Diastolic and Systolic Left Ventricular Function in Septic Shock
Enrollment Status: Completed
Publish Date: October 24, 2019
View 4 Less Clinical Trials

111 Total Publications

Clinical and metabolic phenotyping of continuous versus intermittent ENteral NUTrition in ventilated adults with shock: ENNUT trial protocol.
Clinical and metabolic phenotyping of continuous versus intermittent ENteral NUTrition in ventilated adults with shock: ENNUT trial protocol.
Journal: BMJ open
Published: August 01, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Maizel's expertise for a condition
ConditionClose
      View All 23 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile